Loading...

Embecta Corp.

EMBCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$11.73
$0.35(3.08%)

Embecta Corp. (EMBC) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.4/100

Key Financials

Market Cap685.5M
P/E Ratio13.05
EPS (TTM)$0.89
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$9.58
1 Month$9.57
3 Months$15.24
1 Year Target$15.94

EMBC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.05 and a market capitalization of 685.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;